Galderma issued new data from two investigator-initiated trials (IITs), demonstrating the power of Sculptra – the first proven regenerative biostimulator – and the company’s versatile hyaluronic acid injectable… read more.
Repeated menstrual cycles may do more than trigger endometriosis. They may rewire the brain. That is the key finding from a new Washington State University study showing that… read more.
A new study suggests that probiotics supplementation during early pregnancy may help reduce the risk of recurrent spontaneous preterm delivery (sPTD). In a multicentre clinical trial, pregnant women… read more.
Cornell University scientists have taken a major step toward developing a safe, reversible, long-acting and 100% effective nonhormonal male contraceptive, considered the holy grail of male contraception. A… read more.
NICE (UK): Fezolinetant can be used as an option to treat moderate to severe vasomotor symptoms associated with menopause when hormone replacement therapy is unsuitable. This recommendation is… read more.
Postmenopausal women face a high risk of bone fractures. Due to declines in estrogen levels, which can lead to an increased risk of osteoporosis, even a low-impact fall… read more.
A new Cochrane review finds that chlorhexidine likely cuts umbilical cord infection rates by about 29% in low- and middle-income countries, and may reduce newborn deaths. Umbilical cord… read more.
There appears to be no association between hormonal contraception and the prevalence of idiopathic intracranial hypertension, researchers reported on March 25, 2026 in Neurology, the medical journal of… read more.
Extending the monitoring period for severe pregnancy complications showed more than 40% of cases were missed using traditional delivery-focused monitoring, according to new research published in CMAJ (Canadian Medical Association… read more.
In a clinical trial supported by the National Institutes of Health (NIH), a research team found that administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder… read more.
Premature ovarian insufficiency (POI) is a clinically significant cause of infertility that affects between 1 to 3% of women of childbearing age. Symptoms include absent menses, low estrogen… read more.
A simple 5-minute test addressing major endometriosis diagnostic delays and treatment, has been developed by University of Queensland researchers. The Simplified Adolescent Factors for Endometriosis (SAFE) score uses… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
